Traducción en proceso. Mostrando versión en inglés.

Citizens maintains outperform rating on LeMaitre Vascular stock

ArchivadoFuente Única|2 artículos|1 fuentes|1 bloques

Detectado: Actualizado: Analizado:

Finanzas Salud Resultados

Hechos Reportados

Datos observables compartidos por todas las narrativas

•Citizens maintained an outperform rating on LeMaitre Vascular stock on February 20, 2026
•Citizens reiterated its stock rating on Cushman & Wakefield on the same date

Qué Podría Pasar Si...

▸If LeMaitre Vascular reports strong quarterly earnings Citizens and other investors may increase buying interest in LeMaitre Vascular stock

Inicia sesión para ver todos los escenarios y señales.

Exposición de Mercado

AccionesLeMaitre VascularPresión Alcista

If Citizens maintains an outperform rating, it may encourage investor demand, applying upward pressure on LeMaitre Vascular's stock price

Esto no es asesoramiento de inversión. La exposición de mercado se basa en análisis condicional de eventos.

Actores Clave

Instrumentos

📈Cushman & Wakefield stock 📈LeMaitre Vascular stock

Organizaciones

🏛Citizens 🏛Cushman & Wakefield 🏛LeMaitre Vascular

Cobertura por Fuentes

FINANCE

2 artículos

Más cobertura relacionada

Señales

Single-block coverage

Eventos Relacionados

▸Citizens reiterates CareTrust REIT and Gaming and Leisure stock ratings on 2026 outlookArchivado ▸Citizens lowers Mirum Pharmaceuticals price target on valuationArchivado ▸Fermi stock holds Market Outperform rating at Citizens on data center potentialArchivado ▸Citizens maintains Summit Therapeutics rating on pipeline growthArchivado ▸

Fuentes (2)

FINANCEInvesting.com - NewsLeMaitre Vascular stock rating maintained at outperform by Citizens FINANCEInvesting.com - NewsCitizens reiterates Cushman & Wakefield stock rating on solid 2025

On February 20, 2026, Citizens reaffirmed its outperform rating on LeMaitre Vascular's stock, signaling continued confidence in the company's performance and prospects. This rating suggests that Citizens expects LeMaitre Vascular to perform better than the broader market. The reaffirmation comes alongside Citizens' reiteration of its rating on Cushman & Wakefield, indicating a consistent investment approach across different sectors. LeMaitre Vascular, a medical device company specializing in vascular surgery products, remains a focus for investors monitoring healthcare equities.